Skip to content
How It Works
Explore
Resources Ask a Question
Who It's For
Patients
Decode results, prep for appointments, weigh options.
Caregivers & advocates
Carry the research load for someone you love.
Providers & clinicians
Resources for patients in your practice.
Log In Ask a Question
PubMed This is a summary of 21 peer-reviewed journal articles Updated
Pediatric Ophthalmology

Beyond the NICU: Protecting Vision for a Lifetime

At a Glance

Retinopathy of prematurity (ROP) requires lifelong monitoring even after NICU discharge. Survivors face higher risks of nearsightedness, crossed eyes, and retinal detachment later in life. Strict early follow-up and yearly adult dilated eye exams are essential to protect vision.

The day your baby leaves the NICU is a major milestone, but it is not the end of their eye care journey. Whether your baby’s ROP resolved on its own or required treatment, they will need ongoing monitoring to ensure their vision develops as clearly as possible [1][2].

The Outpatient Transition

The transition from NICU monitoring to outpatient care is a critical time. Your baby’s care team must provide a clear “handoff” to a pediatric ophthalmologist who will continue the screenings [3][4].

Important: If your baby received Anti-VEGF injections, the follow-up must be extremely strict. Because these medications can wear off, the disease can “reactivate” months after discharge [5][6]. Your baby may need weekly or bi-weekly appointments until the doctor confirms the blood vessels have reached the very edge of the retina (full vascularization). This monitoring often extends up to 60-65 weeks Postmenstrual Age (PMA) [7][5].

Long-Term Vision Risks

Even after ROP is considered “resolved,” survivors have a higher risk of certain vision conditions compared to babies born at full term [8][9].

  • Myopia (Nearsightedness): This is the most common long-term issue. ROP survivors are much more likely to need glasses for distance vision [10][11]. High myopia is more common in children who received laser treatment [12].
  • Strabismus (Misaligned Eyes): Premature birth and ROP increase the risk of eyes that cross or turn out [13][14].
  • Amblyopia (“Lazy Eye”): If one eye has a different prescription or alignment than the other, the brain may begin to ignore the weaker eye, leading to permanent vision loss if not treated with patching or glasses early in childhood [13].
  • Glaucoma: In rare cases, especially after surgery for advanced ROP, pressure can build up in the eye, which requires lifelong monitoring [15][16].

Life as an Adult ROP Survivor

The need for an eye doctor (ophthalmologist) does not end in childhood. Adults who had ROP, even if they didn’t need treatment as infants, remain at a lifelong increased risk for retinal detachment [17][18].

  • Late-Onset Detachment: This can happen decades later because the retina of an ROP survivor may have thin spots or areas of scarring from the original disease [19][20].
  • Adult Screening: All ROP survivors should inform their eye doctor of their history and have a dilated fundus exam (an exam where the doctor uses drops to look at the back of the eye) at least once a year [21][17].

Creating a Vision Safety Net

To protect your child’s sight, focus on these three pillars of long-term care:

  1. Strict Early Follow-up: Never miss an appointment in the months immediately following NICU discharge [3].
  2. Early Childhood Exams: Ensure your child has a comprehensive exam before starting school to check for glasses or alignment issues [13].
  3. Lifelong Awareness: As your child grows, teach them that they were born early and have a “unique” retina that needs a yearly check-up by a specialist [21].

By staying vigilant, you are giving your child the best possible chance for a lifetime of healthy vision [1].

Common questions in this guide

Do babies with ROP need eye exams after leaving the NICU?
Yes. Babies with ROP need ongoing outpatient monitoring by a pediatric ophthalmologist. This follow-up is extremely strict if they received anti-VEGF injections, as the disease can reactivate months after they leave the hospital.
What are the long-term vision risks for ROP survivors?
ROP survivors have a higher risk of developing nearsightedness (myopia), crossed or misaligned eyes (strabismus), lazy eye (amblyopia), and rarely, glaucoma. Regular childhood eye exams are needed to catch and treat these issues early.
Can adults who had ROP experience vision problems later in life?
Yes, adult ROP survivors have a lifelong increased risk for late-onset retinal detachment due to thin spots or scarring from the original disease. It is crucial to have a dilated eye exam every year and inform your doctor about your ROP history.
What does full vascularization mean for a baby with ROP?
Full vascularization means the blood vessels in the eye have completely grown to the very edge of the retina. Once this milestone is reached, the immediate risk of ROP reactivating significantly decreases.
When should my child get checked for glasses or a lazy eye?
Your child should have a comprehensive eye exam before starting school, or sooner if recommended by their eye doctor. Early detection and treatments like patching or glasses are critical for preventing permanent vision loss.

Questions to Ask Your Doctor

Curated prompts to bring to your next appointment.

  1. 1.Has my baby's retina reached "full vascularization" (where the vessels reach the edge), or are they still at risk for ROP recurrence?
  2. 2.What is the exact date, time, and location of our first outpatient ophthalmology appointment?
  3. 3.Since my baby received [Laser/Anti-VEGF], what specific follow-up schedule do you recommend for the next 6 months?
  4. 4.What are the early warning signs I should watch for at home that might indicate a vision problem or a recurrence?
  5. 5.At what age should my child have their first comprehensive eye exam for glasses (refraction) or to check for "lazy eye" (strabismus)?

Questions For You

Tap a prompt to share your answer — we'll use it plus this page's context to start a tailored conversation.

References

References (21)
  1. 1

    Caregiver Impact and Understanding of Retinopathy of Prematurity Screening.

    Song W, Hui M, Khitri M, et al.

    Journal of patient experience 2025; (12()):23743735251383261 doi:10.1177/23743735251383261.

    PMID: 41049119
  2. 2

    Knowledge, Attitudes and Practices of Health Workers and Caregivers Towards Retinopathy of Prematurity in Uganda: A Mixed-Methods Study.

    Lusobya RC, Atukunda I, Semulimi AW, et al.

    Public health challenges 2024; (3(3)):e208 doi:10.1002/puh2.208.

    PMID: 40496533
  3. 3

    Screening Examination of Premature Infants for Retinopathy of Prematurity.

    Fierson WM, , , et al.

    Pediatrics 2018; (142(6)) doi:10.1542/peds.2018-3061.

    PMID: 30478242
  4. 4

    A Qualitative Analysis of Challenges and Successes in Retinopathy of Prematurity Screening.

    Bain LC, Kristensen-Cabrera AI, Lee HC

    AJP reports 2018; (8(2)):e128-e133 doi:10.1055/s-0038-1660519.

    PMID: 29896443
  5. 5

    Anti-Vascular Endothelial Growth Factor Therapy for Primary Treatment of Type 1 Retinopathy of Prematurity: A Report by the American Academy of Ophthalmology.

    VanderVeen DK, Melia M, Yang MB, et al.

    Ophthalmology 2017; (124(5)):619-633 doi:10.1016/j.ophtha.2016.12.025.

    PMID: 28341474
  6. 6

    Reactivation of retinopathy of prematurity six years after intravitreal injection of bevacizumab.

    Yasin A, Sinha S, Smith R, et al.

    Journal of AAPOS : the official publication of the American Association for Pediatric Ophthalmology and Strabismus 2023; (27(4)):236-239 doi:10.1016/j.jaapos.2023.05.008.

    PMID: 37451499
  7. 7

    Characteristics of Eyes Developing Retinal Detachment After Anti-vascular Endothelial Growth Factor Therapy for Retinopathy of Prematurity.

    Kondo C, Iwahashi C, Utamura S, et al.

    Frontiers in pediatrics 2022; (10()):785292 doi:10.3389/fped.2022.785292.

    PMID: 35463897
  8. 8

    Long-Term Visual Outcomes in Prematurely Born Children.

    Robitaille JM

    Journal of binocular vision and ocular motility 2024; (74(1)):1-8.

    PMID: 38078812
  9. 9

    Visual function is reduced in young adults formerly born prematurely: a population-based study.

    Pétursdóttir D, Holmström G, Larsson E

    The British journal of ophthalmology 2020; (104(4)):541-546 doi:10.1136/bjophthalmol-2019-314429.

    PMID: 31302630
  10. 10

    Comparison of Intravitreal Bevacizumab, Intravitreal Ranibizumab and Laser Photocoagulation for Treatment of Type 1 Retinopathy of Prematurity in Turkish Preterm Children.

    Kabataş EU, Kurtul BE, Altıaylık Özer P, Kabataş N

    Current eye research 2017; (42(7)):1054-1058 doi:10.1080/02713683.2016.1264607.

    PMID: 28128986
  11. 11

    Refractive and ocular biometric profile of children with a history of laser treatment for retinopathy of prematurity.

    Kaur S, Sukhija J, Katoch D, et al.

    Indian journal of ophthalmology 2017; (65(9)):835-840 doi:10.4103/ijo.IJO_872_16.

    PMID: 28905827
  12. 12

    A Meta-Analysis of Intravitreal Ranibizumab versus Laser Photocoagulation for the Treatment of Retinopathy of Prematurity.

    Baiad AA, Sun C, Yin GS, et al.

    Ophthalmology. Retina 2025; (9(7)):677-689 doi:10.1016/j.oret.2025.01.012.

    PMID: 39842716
  13. 13

    Prevalence of strabismus, nystagmus and risk factors in children and adolescents born preterm with and without retinopathy of prematurity: results from the Gutenberg Prematurity Study Young.

    Fieß A, Gißler S, Hartmann A, et al.

    The British journal of ophthalmology 2026; (110(4)):370-378 doi:10.1136/bjo-2025-327571.

    PMID: 41072940
  14. 14

    Visual outcome and refractive status in first 3 years of age in preterm infants suffered from laser-treated Type 1 retinopathy of prematurity (ROP): a 6-year retrospective review in a tertiary centre in Hong Kong.

    Lok JYC, Yip WWK, Luk ASW, et al.

    International ophthalmology 2018; (38(1)):163-169 doi:10.1007/s10792-016-0439-5.

    PMID: 28054213
  15. 15

    Glaucoma after Lens-Sparing Vitrectomy for Advanced Retinopathy of Prematurity.

    Nudleman E, Muftuoglu IK, Gaber R, et al.

    Ophthalmology 2018; (125(5)):671-675 doi:10.1016/j.ophtha.2017.11.009.

    PMID: 29241743
  16. 16

    Late sequelae of retinopathy of prematurity in adolescence and adulthood.

    Özdemir HB, Özdek S

    Saudi journal of ophthalmology : official journal of the Saudi Ophthalmological Society 2022; (36(3)):270-277 doi:10.4103/sjopt.sjopt_276_21.

    PMID: 36276258
  17. 17

    Late ROP Reactivation and Retinal Detachment in a Teenager.

    Golas L, Shapiro MJ, Blair MP

    Ophthalmic surgery, lasers & imaging retina 2018; (49(8)):625-628 doi:10.3928/23258160-20180803-11.

    PMID: 30114308
  18. 18

    Laser photocoagulation for the treatment of bilateral late-onset retinopathy of prematurity-related retinal detachment in an adult male: A case report.

    Lin TY, Feng KM, Chang YH, Liang IC

    Medicine 2021; (100(22)):e26227 doi:10.1097/MD.0000000000026227.

    PMID: 34087903
  19. 19

    Surgical outcomes of vitreoretinal surgery for rhegmatogenous retinal detachment in eyes with regressed retinopathy of prematurity.

    Sen P, Agarwal A, Bhende P, Gopal L

    Indian journal of ophthalmology 2019; (67(6)):896-902 doi:10.4103/ijo.IJO_706_18.

    PMID: 31124511
  20. 20

    Spontaneous Attachment of Rhegmatogenous Retinal Detachment Following Vitrectomy for Stage 4B Retinopathy of Prematurity and Atypical Retinal Changes Post-Resolution.

    Savla LP, Nene A, Sutar S, Padhi TR

    Ophthalmic surgery, lasers & imaging retina 2018; (49(7)):544-547 doi:10.3928/23258160-20180628-13.

    PMID: 30021044
  21. 21

    Ophthalmic sequelae of prematurity in late childhood and adulthood: A review.

    Downes RA, Rachitskaya AV

    Clinical & experimental ophthalmology 2024; (52(3)):355-364 doi:10.1111/ceo.14358.

    PMID: 38334000

This page provides educational information on long-term vision care for ROP survivors. It does not replace professional medical advice or routine monitoring from a qualified pediatric ophthalmologist.

Get notified when new evidence is published on Retinopathy of prematurity.

We monitor PubMed for new peer-reviewed studies on this topic and email a short summary when something meaningful changes.